Dr. Stephen O. Pastan

Dr. Eric M. Gibney is a program director for Piedmont Transplant Institute. He is a transplant nephrologist who specializes in kidney diseases and transplantation. Dr. Gibney's special interests include living kidney donation, transplant outreach, kidney disease in patients with liver disease, transplantation in HIV and clinical immunosuppression. He is involved with national committee work in living donor paired exchange, patient safety, and fellowship education in addition to being the Mason Endowed Chair in Transplant Services. Prior to joining Piedmont Transplant Institute, Dr. Gibney was a transplant nephrologist with the Division of Nephrology at the Hume-Lee Transplant Center at Virginia Commonwealth University. Dr. Gibney received his medical degree from Emory University School of Medicine and completed his fellowship in renal transplantation and nephrology at the University of Colorado Health Sciences Center in Denver. He completed his residency at New York University School of Medicine where he was also chief medical resident. He also performed post-graduate work in clinical research and biostatistics at the University of Colorado. Dr. Gibney is board certified in internal medicine and nephrology and has been published in numerous medical journals. Dr. Gibney is rated as an Advanced provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Chronic Kidney Disease, and Kidney Transplant.

Dr. Joshua Wolf is a transplant nephrologist at Piedmont Transplant Institute who specializes in kidney diseases and transplantation. Dr. Wolf has a special interest in living donor transplantation as well as transplanting the highly-sensitized recipient. He is board certified in Internal Medicine and Nephrology by the American Board of Internal Medicine. He received his undergraduate and medical degrees from Emory University School of Medicine, completed his internship and residency at New York University Medical Center and his general and transplant nephrology training at the University of California, San Francisco. Hospital Affiliation Piedmont Atlanta Hospital Specialty Kidney Diseases and Transplantation Nephrology Transplant Nephrology Board Certification American Board of Internal Medicine Special Interests Transplanting the highly sensitized recipient Education and Training Medical School:Emory University School of Medicine Internship:New York University Medical Center Residency:New York University Medical Center. Dr. Wolf is rated as an Advanced provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, Magnesium Deficiency, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Klein received her bachelors of science in ecology and evolutionary biology from the University of Arizona where she graduated Magna Cum Laude. Dr. Klein earned her medical degree from UCLA School of Medicine in Los Angeles, Calif. She completed her residency in internal medicine at UCSF in San Francisco, Calif. Her fellowship in nephrology was completed at the University of Colorado. In addition to her nephrology fellowship, she finished a medical transplant fellowship at the University of Wisconsin. Prior to joining Piedmont Transplant Institute, Dr. Klein was a transplant nephrologist at Washington University School of Medicine as the Medical Director for high risk kidney transplantation and pancreas transplantation. She also served as the Transplant Fellowship Program Director. Dr. Klein has been practicing medicine for 13 years and is board certified in internal medicine and nephrology. She is also a member of the American Society of Transplantation and the American Society of Nephrology. Dr. Klein welcomes new patients and accepts most insurance plans. Dr. Klein is rated as an Advanced provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Cytomegalovirus Infection, Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, and Kidney Transplant.